Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,725,013
-$545,661 QoQ
Shares Held
113,165
-2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#836
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $167,982,283 across 14 Drug Manufacturers - General names. PFE ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
63,152 | $75,746,409 | |
| 2 | ABBV |
AbbVie Inc.
|
128,509 | $32,338,004 | |
| 3 | JNJ |
Johnson & Johnson
|
127,237 | $32,314,380 | |
| 4 | AMGN |
Amgen Inc
|
15,849 | $5,739,239 | |
| 5 | MRK |
Merck & Co., Inc.
|
43,565 | $5,598,102 | |
| 6 | PFE |
Pfizer Inc
This page
|
113,165 | $2,725,013 | |
| 7 | NVO |
Novo Nordisk A S
|
56,457 | $2,706,548 | |
| 8 | NVS |
Novartis AG
|
16,577 | $2,597,947 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,725,013 | 113,165 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,270,674 | 116,477 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,976,570 | 119,541 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,141,378 | 123,288 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,061,124 | 126,284 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $4,149,374 | 163,748 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,336,147 | 125,750 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,928,887 | 170,314 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $5,009,679 | 179,045 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,420,378 | 231,365 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,158,209 | 213,901 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $5,086,752 | 153,354 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,973,301 | 162,849 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,321,992 | 130,441 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $19,085,055 | 372,464 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $12,484,859 | 285,303 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,413,342 | 122,322 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,947,492 | 114,883 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $6,793,997 | 115,055 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,905,918 | 137,315 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,039,737 | 26,551 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,315,438 | 36,308 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $4,730,894 | 128,522 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,276,792 | 62,038 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $199,274 | 6,094 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $191,074 | 5,854 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||